Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
London close: Stocks slip as investors digest UK, US data
3 September 2024 15:51
(Sharecast News) - London stocks ended Tuesday in negative territory as investors reacted to the latest UK retail sales date, and a fresh manufacturing sector reading out of the US.
-
Berenberg upgrades Hikma Pharmaceuticals to 'buy'
3 September 2024 09:44
(Sharecast News) - Berenberg upgraded Hikma Pharmaceuticals on Tuesday and lifted the price target to 2,400p from 2,100p as it said "clear progress" had been made.
-
London close: Stocks buoyed by solid economic data
15 August 2024 15:30
(Sharecast News) - London stocks ended Thursday on a positive note, buoyed by data confirming expected growth in the UK economy for the second quarter.
-
Berenberg raises target price on Hikma Pharmaceuticals following H1 results
13 August 2024 09:13
(Sharecast News) - Analysts at Berenberg raised their target price on Hikma Pharmaceuticals from 2,000.0p to 2,100.0p on Tuesday following an "impressive" H1 performance.
-
London close: Stocks claw back losses but still finish lower
8 August 2024 14:57
(Sharecast News) - London markets ended Thursday on a weaker note despite recovering some earlier losses, as concerns over a potential US recession weighed on investor sentiment.
-
Hikma Pharmaceuticals outlines 'excellent' H1, upgrades FY guidance
8 August 2024 08:02
(Sharecast News) - Pharmaceutical company Hikma Pharmaceuticals shares were in the green early on Thursday after the group's H1 results pointed to an "excellent" start to the year and upgraded...
-
London close: Stocks mixed ahead of key UK inflation data
17 June 2024 15:49
(Sharecast News) - London stocks ended Monday with a mixed performance as renewed concerns over French political uncertainty weighed on investors' minds.
-
Hikma boosts injectables business with Xellia assets acquisition
17 June 2024 07:42
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and...
-
Citi hikes Hikma price target, cites 'healthy trends' for injectables and US Generics
11 June 2024 08:45
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "healthy trends" for injectables and US Generics.
-
London close: Stocks finish mixed as US GDP growth slows
25 April 2024 15:14
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of...
-
Hikma delivers strong Q1, holds on to guidance
25 April 2024 08:01
(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing well, as it held on to guidance for the year.
-
London close: Stocks rise as BoE keeps rates on hold
21 March 2024 16:33
(Sharecast News) - London markets closed higher on Thursday, sustaining gains after the Bank of England adhered to expectations by maintaining interest rates at a 16-year high.
Company announcements Announcements
-
Block listing Interim Review
1 October 2024 09:45
Hikma Pharmaceuticals
-
Director/PDMR Shareholding
24 September 2024 10:09
Hikma Pharmaceuticals
-
Hikma completes Xellia acquisition
10 September 2024 07:00
Hikma Pharmaceuticals
-
Director/PDMR Shareholding
13 August 2024 09:39
Hikma Pharmaceuticals
-
Half-year Report
8 August 2024 07:00
Hikma Pharmaceuticals
-
Director Declaration
29 July 2024 16:08
Hikma Pharmaceuticals
-
Notice of Results
15 July 2024 07:00
Hikma Pharmaceuticals
-
Total Voting Rights
1 July 2024 14:47
Hikma Pharmaceuticals
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.